Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NeuroChat with Professor Danny Winder.

ACS chemical neuroscience·2019
Same author

Biased M<sub>1</sub> receptor-positive allosteric modulators reveal role of phospholipase D in M<sub>1</sub>-dependent rodent cortical plasticity.

Science signaling·2019
Same author

Discovery of structurally distinct tricyclic M<sub>4</sub> positive allosteric modulator (PAM) chemotypes.

Bioorganic & medicinal chemistry letters·2019
Same author

Discovery of a novel 2,3-dimethylimidazo[1,2-a]pyrazine-6-carboxamide M<sub>4</sub> positive allosteric modulator (PAM) chemotype.

Bioorganic & medicinal chemistry letters·2019
Same author

Crystal structure of the M<sub>5</sub> muscarinic acetylcholine receptor.

Proceedings of the National Academy of Sciences of the United States of America·2019
Same author

mGlu<sub>2</sub> and mGlu<sub>3</sub> Negative Allosteric Modulators Divergently Enhance Thalamocortical Transmission and Exert Rapid Antidepressant-like Effects.

Neuron·2019
Same journal

Quantitative Assessment of Neurometabolism by Deuterium and Proton NMR Spectroscopy Using [6,6'-<sup>2</sup>H<sub>2</sub>]Glucose.

ACS chemical neuroscience·2026
Same journal

NLX-112, a Selective 5-HT<sub>1A</sub> Receptor Agonist, Upregulates GDNF and is Neuroprotective Against MPTP-Induced Nigrostriatal Degeneration in a Mouse Model of Parkinson's Disease.

ACS chemical neuroscience·2026
Same journal

Bithiophene Scaffold for PET Imaging and Photosensitization as a Novel Theranostic Platform Targeting Amyloid-β Aggregates.

ACS chemical neuroscience·2026
Same journal

Low Agonism and Balanced Pathway Modulation Distinguish an M1 Muscarinic Receptor Positive Allosteric Modulator Lacking Cholinergic Adverse Effects.

ACS chemical neuroscience·2026
Same journal

Imaging Synaptic Vesicle Protein SV2C with <sup>18</sup>F-UCB-F: An In Vitro Autoradiography and In Vivo NHP PET Study.

ACS chemical neuroscience·2026
Same journal

UBOX5 Modulates the Cognitive Dysfunction by Degrading HSP70 Protein in Sleep-Deprived Mice.

ACS chemical neuroscience·2026
See all related articles

Related Experiment Video

Updated: May 13, 2026

Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis
08:48

Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis

Published on: January 29, 2016

New hope for multiple sclerosis patients

Craig W Lindsley

    ACS Chemical Neuroscience
    |March 21, 2013
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
    10:44

    Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

    Published on: February 22, 2015

    Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
    09:24

    Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

    Published on: April 15, 2014

    Related Experiment Videos

    Last Updated: May 13, 2026

    Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis
    08:48

    Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis

    Published on: January 29, 2016

    Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
    10:44

    Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

    Published on: February 22, 2015

    Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
    09:24

    Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

    Published on: April 15, 2014